Endothelial function measured by peripheral arterial tonometry in patients with chronic myeloid leukemia on tyrosine kinase inhibitor therapy: a pilot study

被引：0
|
作者：
Tomohiro Kaneko
Sakiko Miyazaki
Azusa Kurita
Ryoko Morimoto
Shun Tsuchiya
Naoki Watanabe
Tomoiku Takaku
Norio Komatsu
Tohru Minamino
机构：
[1] Juntendo University Graduate School of Medicine,Department of Cardiovascular Biology and Medicine
[2] Juntendo University Graduate School of Medicine,Department of Hematology
来源：
Cardio-Oncology | / 9卷
关键词：
Tyrosine kinase inhibitors; Chronic myeloid leukemia; Endothelial dysfunction; Uric acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the “Best” Therapy?
    Meetu Agrawal
    Ravin J. Garg
    Hagop Kantarjian
    Jorge Cortes
    Current Oncology Reports, 2010, 12 : 302 - 313
  • [32] Thrombopoietin Levels During Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia
    Takashi Hamada
    Noriyoshi Iriyama
    Hiromichi Takahashi
    Katsuhiro Miura
    Yoshihito Uchino
    Masaru Nakagawa
    Yoshihiro Hatta
    Masami Takei
    Clinical Drug Investigation, 2018, 38 : 813 - 818
  • [33] Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the "Best" Therapy?
    Agrawal, Meetu
    Garg, Ravin J.
    Kantarjian, Hagop
    Cortes, Jorge
    CURRENT ONCOLOGY REPORTS, 2010, 12 (05) : 302 - 313
  • [34] Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in China
    Qian Jiang
    Robert Peter Gale
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1549 - 1555
  • [35] Breastfeeding in a patient with chronic myeloid leukemia during tyrosine kinase inhibitor therapy
    Terao, Ryuta
    Nii, Mitsumaro
    Asai, Hiroko
    Nohara, Fumikatsu
    Okamoto, Toshio
    Nagaya, Ken
    Azuma, Hiroshi
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 756 - 760
  • [36] Thrombopoietin Levels During Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia
    Hamada, Takashi
    Iriyama, Noriyoshi
    Takahashi, Hiromichi
    Miura, Katsuhiro
    Uchino, Yoshihito
    Nakagawa, Masaru
    Hatta, Yoshihiro
    Takei, Masami
    CLINICAL DRUG INVESTIGATION, 2018, 38 (09) : 813 - 818
  • [37] Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot Study
    Leader, Avi
    Gafter-Gvili, Anat
    Benyamini, Noam
    Dreyer, Juliet
    Calvarysky, Bronya
    Amitai, Alina
    Yarchovsky-Dolberg, Osnat
    Sharf, Giora
    Tousset, Eric
    Caspi, Opher
    Ellis, Martin
    Levi, Itai
    Raanani, Pia
    De Geest, Sabina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (09): : E351 - E362
  • [38] Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: What Is the Best Therapy?
    Quintas-Cardama, Alfonso
    Cortes, Jorge
    CURRENT ONCOLOGY REPORTS, 2009, 11 (05) : 337 - 345
  • [39] Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in China
    Jiang, Qian
    Gale, Robert Peter
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (07) : 1549 - 1555
  • [40] Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the best therapy?
    Alfonso Quintás-Cardama
    Jorge Cortes
    Current Oncology Reports, 2009, 11 : 337 - 345
12345